Article
Search for the tumor-related proteins of transition cell carcinoma in Taiwan by proteomic analysis.
Department of Urology, Chi-Mei Medical Center, Tainan, Taiwan.
PROTEOMICS (impact factor:
4.51).
03/2006;
6(3):1058-65.
DOI:10.1002/pmic.200402015
pp.1058-65
Source: PubMed
-
Citations (0)
- Cited In (2)
-
Article: Body cooling causes normalization of cardiac protein expression and function in a rat heatstroke model.
[show abstract] [hide abstract]
ABSTRACT: Cardiac dysfunction contributes to heatstroke genesis, which can be ameliorated by whole body cooling. A comparative analysis using two-dimensional in-gel electrophoresis of cardiac protein patterns is performed in rat controls, untreated heatstroke rats, and whole body cooling-treated heatstroke rats. After the onset of heatstroke, animals display hypotension and altered cardiac protein profiles, which can be reversed by whole body cooling. Thus, the proteomic mechanisms exerted by body cooling during heatstroke are elucidated by the current results.Journal of Proteome Research 10/2008; 7(11):4935-45. · 5.11 Impact Factor -
Article: Heat shock proteins in oncology: Diagnostic biomarkers or therapeutic targets?
[show abstract] [hide abstract]
ABSTRACT: Heat shock proteins (HSP) are a family of proteins induced in cells exposed to different insults. This induction of HSPs allows cells to survive stress conditions. Mammalian HSPs have been classified into six families according to their molecular size: HSP100, HSP90, HSP70, HSP60, HSP40 and small HSPs (15 to 30kDa) including HSP27. These proteins act as molecular chaperones either helping in the refolding of misfolded proteins or assisting in their elimination if they become irreversibly damaged. In recent years, proteomic studies have characterized several different HSPs in various tumor types which may be putative clinical biomarkers or molecular targets for cancer therapy. This has led to the development of a series of molecules capable of inhibiting HSPs. Numerous studies speculated that over-expression of HSP is in part responsible for resistance to many anti-tumor agents and chemotherapeutics. Hence, from a pharmacological point of view, the co-administration of HSP inhibitors together with other anti-tumor agents is of major importance in overcoming therapeutic resistance. In this review, we provide an overview of the current status of HSPs in autoimmune, cardiovascular, and neurodegenerative diseases with special emphasis on cancer.Biochimica et Biophysica Acta 05/2011; 1816(2):89-104. · 4.66 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
15-hydroxyprostaglandin dehydrogenase
bladder cancer
bladder cancers
deregulated proteins
differential protein expression
fatty acid binding proteins
grade III samples
grade III TCC
heat-shock protein 27
high-grade tumors
hydratase 1 precursor
III TCC samples
immunohistochemical staining
mitochondrial short-chain enoyl-coenzyme
molecular fingerprinting
pathological mechanisms
potential biomarkers
proteins up-regulated
seven proteins
transitional cell carcinoma